3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
8
Rhabdoid Tumor
7
Osteosarcoma
7
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Sarcoma
6
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Glioma
6
Ependymoma
6
Central Nervous System Neoplasms
5
Sarcoma, Ewing
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Nasopharyngeal Carcinoma
2
Immunoglobulin Light-chain Amyloidosis
2
Endometrial Neoplasms
2
Desmoid Tumors
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Thyroid Cancer, Papillary
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Synovial
1
Interventions
Cyclophosphamide
23
fludarabine
14
Rituximab
14
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Doxorubicin
7
pirtobrutinib
6
Vincristine
6
Prednisone
6
zanubrutinib
4
polatuzumab vedotin
4
obinutuzumab
4
Nivolumab
4
Etoposide
4
Dexamethasone
4
Biopsy
4
tazemetostat
3
tafasitamab
3
pembrolizumab
3
ibrutinib
3
glofitamab
3
fludarabine phosphate
3
acalabrutinib
3
Immunotherapy, Adoptive
3
Bendamustine Hydrochloride
3
venetoclax
2
pomalidomide
2
etoposide phosphate
2
cemiplimab
2
Prednisolone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Phantoms, Imaging
×
90 days
×
Clear all
No trials found.